Animation - Understanding AML-MRC and tAML

This animation provides an overview of acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) and treatment-related acute myeloid leukemia (tAML). It also describes the causes, risk factors, and symptoms of AML-MRC and tAML. Both AML-MRC and tAML are “secondary” types of AML because they occur after a person has had MDS or another type of cancer. AML that starts abruptly with no known prior exposure to chemotherapy or radiation and no prior cancer diagnosis is called “de novo” AML and is discussed in another segment in this series.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.

Please rate this content:

This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AbbVie, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.